NVAX reports encouraging fourth-quarter results ... loss and said it expects its licensing deal with French drugmaker Sanofi for COVID-19 vaccines to generate royalties, and reduce selling ...

The CDC has rescheduled a key advisory committee meeting on vaccine experts to April following a delay in February, a week ...

The White House is reportedly considering former U.S. Rep. Michael Burgess (R-Texas) as its nominee to head the CDC. Burgess, ...

Novavax (US:NVAX) had been working on a protein-based Covid-19 vaccine ... Jobs have been cut, a distribution agreement with Sanofi signed, and it plans to develop a combination vaccine for Covid-19.

The CDC has rescheduled a key advisory committee meeting on vaccine experts to April following a delay in February, a week after Robert F. Kennedy Jr.’s confirmation as the Secretary of Health ...

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...